Logo image of BTSG

BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis

NASDAQ:BTSG - Nasdaq - US10950A1060 - Common Stock - Currency: USD

19.37  -0.27 (-1.37%)

After market: 19.36 -0.01 (-0.05%)

Fundamental Rating

4

Overall BTSG gets a fundamental rating of 4 out of 10. We evaluated BTSG against 103 industry peers in the Health Care Providers & Services industry. BTSG has a medium profitability rating, but doesn't score so well on its financial health evaluation. BTSG has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year BTSG was profitable.
BTSG had a positive operating cash flow in the past year.
In multiple years BTSG reported negative net income over the last 5 years.
Of the past 5 years BTSG 4 years had a positive operating cash flow.
BTSG Yearly Net Income VS EBIT VS OCF VS FCFBTSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of BTSG (0.98%) is comparable to the rest of the industry.
BTSG has a Return On Equity of 3.39%. This is comparable to the rest of the industry: BTSG outperforms 57.28% of its industry peers.
BTSG has a Return On Invested Capital (4.48%) which is comparable to the rest of the industry.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.55%.
The 3 year average ROIC (3.45%) for BTSG is below the current ROIC(4.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROIC 4.48%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSG Yearly ROA, ROE, ROICBTSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 0.49%, BTSG is in line with its industry, outperforming 51.46% of the companies in the same industry.
BTSG has a Operating Margin (2.15%) which is in line with its industry peers.
BTSG's Operating Margin has improved in the last couple of years.
BTSG has a worse Gross Margin (13.46%) than 68.93% of its industry peers.
BTSG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSG Yearly Profit, Operating, Gross MarginsBTSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BTSG is destroying value.
The number of shares outstanding for BTSG has been increased compared to 1 year ago.
Compared to 5 years ago, BTSG has more shares outstanding
Compared to 1 year ago, BTSG has an improved debt to assets ratio.
BTSG Yearly Shares OutstandingBTSG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSG Yearly Total Debt VS Total AssetsBTSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 2.79 indicates that BTSG is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.79, BTSG is in the better half of the industry, outperforming 62.14% of the companies in the same industry.
BTSG has a debt to FCF ratio of 19.98. This is a negative value and a sign of low solvency as BTSG would need 19.98 years to pay back of all of its debts.
BTSG's Debt to FCF ratio of 19.98 is in line compared to the rest of the industry. BTSG outperforms 41.75% of its industry peers.
A Debt/Equity ratio of 1.48 is on the high side and indicates that BTSG has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.48, BTSG is doing worse than 70.87% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Altman-Z 2.79
ROIC/WACC0.52
WACC8.65%
BTSG Yearly LT Debt VS Equity VS FCFBTSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.73 indicates that BTSG should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.73, BTSG is in the better half of the industry, outperforming 64.08% of the companies in the same industry.
BTSG has a Quick Ratio of 1.37. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
BTSG has a Quick ratio (1.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.37
BTSG Yearly Current Assets VS Current LiabilitesBTSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

6

3. Growth

3.1 Past

BTSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.85%, which is quite impressive.
The Revenue has grown by 27.65% in the past year. This is a very strong growth!
BTSG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.01% yearly.
EPS 1Y (TTM)92.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
Revenue 1Y (TTM)27.65%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%

3.2 Future

BTSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.97% yearly.
BTSG is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.63% yearly.
EPS Next Y56.48%
EPS Next 2Y39.35%
EPS Next 3Y31.48%
EPS Next 5Y29.97%
Revenue Next Year9.89%
Revenue Next 2Y11.06%
Revenue Next 3Y11.46%
Revenue Next 5Y7.63%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BTSG Yearly Revenue VS EstimatesBTSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
BTSG Yearly EPS VS EstimatesBTSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5 2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

BTSG is valuated quite expensively with a Price/Earnings ratio of 26.18.
Compared to the rest of the industry, the Price/Earnings ratio of BTSG is on the same level as its industry peers.
When comparing the Price/Earnings ratio of BTSG to the average of the S&P500 Index (26.82), we can say BTSG is valued inline with the index average.
A Price/Forward Earnings ratio of 18.14 indicates a rather expensive valuation of BTSG.
Based on the Price/Forward Earnings ratio, BTSG is valued a bit cheaper than 60.19% of the companies in the same industry.
BTSG is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 26.18
Fwd PE 18.14
BTSG Price Earnings VS Forward Price EarningsBTSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BTSG's Enterprise Value to EBITDA is on the same level as the industry average.
BTSG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.8
EV/EBITDA 13.34
BTSG Per share dataBTSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

BTSG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BTSG's earnings are expected to grow with 31.48% in the coming years.
PEG (NY)0.46
PEG (5Y)N/A
EPS Next 2Y39.35%
EPS Next 3Y31.48%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BTSG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRIGHTSPRING HEALTH SERVICES

NASDAQ:BTSG (8/4/2025, 4:04:04 PM)

After market: 19.36 -0.01 (-0.05%)

19.37

-0.27 (-1.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners53.2%
Inst Owner Change0.44%
Ins Owners2.93%
Ins Owner Change19.83%
Market Cap3.42B
Analysts84.21
Price Target28.67 (48.01%)
Short Float %17.94%
Short Ratio6.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.16%
Min EPS beat(2)-2.7%
Max EPS beat(2)97.01%
EPS beat(4)1
Avg EPS beat(4)3.84%
Min EPS beat(4)-40.94%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.12%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.86%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.71%
PT rev (3m)13.87%
EPS NQ rev (1m)-3.63%
EPS NQ rev (3m)34.23%
EPS NY rev (1m)1.38%
EPS NY rev (3m)47.27%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)2.97%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)3.21%
Valuation
Industry RankSector Rank
PE 26.18
Fwd PE 18.14
P/S 0.3
P/FCF 26.8
P/OCF 16.73
P/B 2.02
P/tB N/A
EV/EBITDA 13.34
EPS(TTM)0.74
EY3.82%
EPS(NY)1.07
Fwd EY5.51%
FCF(TTM)0.72
FCFY3.73%
OCF(TTM)1.16
OCFY5.98%
SpS65.58
BVpS9.57
TBVpS-7.09
PEG (NY)0.46
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROCE 5.67%
ROIC 4.48%
ROICexc 4.54%
ROICexgc 14.07%
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
FCFM 1.1%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Debt/EBITDA 5.59
Cap/Depr 38.81%
Cap/Sales 0.66%
Interest Coverage 1.22
Cash Conversion 45.71%
Profit Quality 222.79%
Current Ratio 1.73
Quick Ratio 1.37
Altman-Z 2.79
F-Score6
WACC8.65%
ROIC/WACC0.52
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%120%
EPS Next Y56.48%
EPS Next 2Y39.35%
EPS Next 3Y31.48%
EPS Next 5Y29.97%
Revenue 1Y (TTM)27.65%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%15.29%
Revenue Next Year9.89%
Revenue Next 2Y11.06%
Revenue Next 3Y11.46%
Revenue Next 5Y7.63%
EBIT growth 1Y60.42%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year54.27%
EBIT Next 3Y23.8%
EBIT Next 5YN/A
FCF growth 1Y-141.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.72%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%